Prognostic value of troponin i levels for predicting adverse cardiovascular outcomes in postmenopausal women undergoing cardiac surgery

Anesthesia and Analgesia

Volumn 108, Issue 3, 2009, Pages 719-726

  Stearns, Joshua D ^a   Dávila Román, Victor G ^b   Barzilai, Benico ^b   Thompson, Richard E ^c   Grogan, Kelly L ^a   Thomas, Betsy ^b   Hogue Jr , Charles W ^a,d  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; PLACEBO; TROPONIN I;

ADVERSE OUTCOME; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; ESTROGEN THERAPY; FEMALE; FORWARD HEART FAILURE; HEART INDEX; HEART INFARCTION; HUMAN; INTENSIVE CARE UNIT; NEUROPROTECTION; OUTCOME ASSESSMENT; PATIENT MONITORING; PHYSICIAN; POSTMENOPAUSE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; Q WAVE; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SURGICAL MORTALITY; BLOOD; ELECTROCARDIOGRAPHY; HEART SURGERY; MIDDLE AGED; PERIOPERATIVE PERIOD; PREDICTION AND FORECASTING; ROC CURVE; STATISTICAL MODEL; TREATMENT OUTCOME;

AGED; CARDIAC OUTPUT, LOW; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR DISEASES; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; ESTRADIOL; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROC CURVE; TREATMENT OUTCOME; TROPONIN I;

EID: 61949128321     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318193fe73     Document Type: Article

References (32)

1. Edwards FH, Carey JS, Grover FL, Bero JW, Hartz RS. Impact of gender on coronary bypass operative mortality. Ann Thorac Surg 1998;66:125-31
2. Hogue CW, Murphy SF, Schechtman KB, Davila-Roman VG. Risk factors for early or delayed stroke after cardiac surgery. Circulation 1999;100:642-7
3. Hogue CW, Sundt TM, Barzilai B, Schecthman K, Davila-Roman VG. Cardiac and neurologic complications identify risks for mortality for both men and women undergoing coronary artery bypass graft surgery. Anesthesiology 2001;95:1074-8
4. Hogue CW, Barzilai B, Pieper KS, Coombs LP, DeLong ER, Kouchoukos NT, Davila-Roman VG. Sex differences in neurological outcomes and mortality after cardiac surgery: a society of thoracic surgery national database report. Circulation 2001;103:2133-7
5. Koch CG, Khandwala F, Nussmeier N, Blackstone EH. Gender and outcomes after coronary artery bypass grafting: a propensity-matched comparison. J Thorac Cardiovasc Surg 2003;126:2032- 43
6. Adams JE III, Bodor GS, Da'vila-Roma'n VG, Delmez JA, Apple FS, Landenson JH, Jaffe AS. Troponin I: a marker with high specificity for cardiac injury. Circulation 1993;88:101-6
7. Croal BL, Hillis GS, Gibson PH, Fazal MT, El-Shafei H, Gibson G, Jeffrey RR, Buchan KG, West D, Cuthbertson BH. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation 2006;114:1468-75
8. Lasocki S, Provenchere S, Benessiano J, Vicaut E, Lecharney JB, Desmonts JM, Dehoux M, Philip I. Cardiac troponin I is an independent predictor of in-hospital death after cardiac surgery. Anesthesiology 2002;97:405-11
9. Fellahi JL, Gue X, Richomme X, Monier E, Guillou L, Riou B. Short- and long-term prognostic value of postoperative cardiac troponin I concentrations in patients undergoing coronary artery bypass grafting. Anesthesiology 2003;99:270-4
10. Jacquet L, Noirhomme P, El Khoury G, Goenen M, Philippe M, Col J, Dion R. Cardiac troponin I as an early marker of myocardial damage after coronary artery bypass surgery. Eur J Cardiothorac Surg 1998;13:378-84
11. Gensini GF, Fusi C, Conti AA, Calamai GC, Montesi GF, Galanti G, Noferi D, Carbonetto F, Palmarini MF, Abbate R, Vaccari M. Cardiac troponin I and Q-wave perioperative myocardial infarction after coronary artery bypass surgery. Crit Care Med 1998;26:1986-90
12. Alyanakian MA, Dehoux M, Chatel D, Seguret C, Desmonts JM, Durand G, Philip I. Cardiac troponin I in diagnosis of perioperative myocardial infarction after cardiac surgery. J Cardiothorac Vasc Anesth 1998;12:288-94
13. Etievent JP, Chocron S, Toubin G, Taberlet C, Alwan K, Clement F, Cordier A, Schipman N, Kantelip JP. Use of cardiac troponin I as a marker of perioperative myocardial ischemia. Ann Thorac Surg 1995;59:1192-94
14. Carrier M, Pellerin M, Perrault LP, Solymoss BC, Pelletier LC. Troponin levels in patient with myocardial infarction after coronary artery bypass grafting. Ann Thorac Surg 2000;69:435-40
15. Eigel P, van Ingen G, Wagenpfeil S. Predictive value of perioperative cardiac troponin I for adverse outcome in coronary artery bypass surgery. Eur J Cardiothoracic Surg 2001;20:544-9
16. Horvath KA, Parker MA, Frederiksen JW, Palmer AS, Fullerton DA. Postoperative troponin I values: insult or injury? Clin Cardiol 2000;23:731-3
17. Schwarzenberger JC, Sun LS, Pesce M, Heyer EJ, Delphin E, Almeida GM, Wood M. Sex-based differences in serum cardiac troponin I, a specific marker for myocardial injury, after cardiac surgery. Crit Care Med 2003;31:689-93
18. Hogue CW, Freedland K, Hershey T, Fucetola R, Nassief A, Barzilai B, Thomas B, Birge S, Dixon D, Schechtman KB, Da'vila-Roma'n VG. Neurocognitive Outcomes are not Improved by 17-estradiol in postmenopausal women undergoing cardiac surgery. Stroke 2007;38:2048-54
19. De Bruyne B, Hersbach F, Pijls HN, Bartunek J, Bech JW, Heyndrickx GR, Gould KL, Wijns W. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "normal" coronary angiography. Circulation 2001;104:2401-6
20. Webb CM, Ghatei MA, McNeill JG, Collins P. 17-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease. Circulation 2000;102:1617-22
21. Guetta V, Quyyumi AA, Prasad A, Panza JA, Waclawiw M, Cannon RO. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation 1997;96: 2795-801
22. Chocron S, Alwan K, Toubin G, Taberlet C, Alwan K, Clement F, Cordier A, Schipman N, Kantelip JP. Crystalloid cardiopulegia route of delivery and cardiac troponin I release. Ann Thorac Surg 1996;59:1192-94
23. Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH. National academy of clinical biochemistry and IFCC committee for standardization of markers of cardiac damage laboratory med practice guidelines: analytical issues for biochemical markers of acute coronary syndromes. Circulation 2007;115:e352-e355
24. Collins P, Rosano GM, Jiang C, Lindsey D, Sarrel PM, Poole- Wilson PA. Cardiovascular protection by oestrogen-a calcium antagonist effect? Lancet 1993;341:1264-5
25. Sudhir K, Chou TM, Mullen WL, Hausmann D, Collins P, Yock PG, Catterjee K. Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. J Am Coll Cardiol 1995;26:807-14
26. Node K, Kitakaze M, Kosaka H, Minamino T, Funaya H, Hori M. Amelioration of ischemia- and reperfusion-induced myocardial injury by 17-estradiol: role of nitric oxide and calciumactivated potassium channels. Circulation 1997;96:1953-63
27. Caulin-Gaser T, Watson CA, Pardi R Jr B. Effect of 17 beta estradiol on cytokine induced endothelial cell adhesion molecule expression. J Clin Invest 1996;98:336-42
28. Nishino M, Youn HJ, Gheorghevici D, Zellner C, Chou TM, Sudhir K, Redberg RF. Effect of intracoronary estradiol on postischemic microvascular damage in a porcine model: a myocardial contrast echocardiographic study. Angiology 2003;54:701-9
29. Lee TM, Su SF, Tsai CC, Lee YT, Chang-Hen T. Cardiovascular effects of 17-estradiol produced by activation of mitochondrial ATP-sensitive K- channels in canine hearts. J Mol Cell Cardiol 2000;32:1147-58
30. Kyriakides ZS, Lymberopoulos E, Papalois A, Kyrzopoulos S, Dafnomili V, Sbarouni E, Kremastinos DT. Estrogen decreases neointimal hyperplasia and improves re-endothelialization in pigs. Int J Cardiol 2006;113:48-53
31. Strehlow K, Warner N, Berweiler J, Dirnagl U, Priller J, Laufs K, Ghaeni L, Milosevic M, Böhm M, Nickenig G. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003;107:3059-65
32. Hiratzka LF, Eagle KA, Liang L, Fonarow GC, LaBresh KA, Peterson ED; Get with the Guidelines Steering Committee. Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention pathway in the guideline database. Circulation 2007;116:I207-I212